OKYO Pharma Limited
OKYO
$2.43
$0.062.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 74.70% | 74.70% | 69.61% | 69.61% | -2.89% |
| Total Depreciation and Amortization | -22.22% | -22.22% | -40.00% | -40.00% | -18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -69.31% | -69.31% | -98.27% | -98.27% | 400.05% |
| Change in Net Operating Assets | -165.95% | -165.95% | 66.81% | 66.81% | -56.09% |
| Cash from Operations | 41.81% | 41.81% | 96.45% | 96.45% | 35.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.67% | -47.67% | -86.25% | -86.25% | -55.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.74% | -4.74% | -86.21% | -86.21% | -70.69% |
| Foreign Exchange rate Adjustments | 113.47% | 113.47% | -141.15% | -141.15% | -8.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.58% | 172.58% | 106.61% | 106.61% | -125.86% |